InvestorsHub Logo

a1derfullife

01/31/13 2:16 PM

#22775 RE: a1derfullife #22768

Also, in the pre-clinical trials, Kevetrin was tested by itself. Given that Kevetrin's MOA is different from that of all currently approved cancer drugs, it's highly likely that, in phase 2 trials, Kevetrin will be administered in conjunction with currently approved cancer meds, thereby increasing the likelihood of positive results even further.

A1